Bharat Biotech starts human trial of its anti-Covid vaccine at PGI

Last Updated on July 17, 2020 by The Health Master

CHANDIGARH: The human trial of Bharat Biotech’s anti-Covid-19 vaccineCovaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences on Friday, Haryana Health minister Anil Vij tweeted. “Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today,” Vij, who is also the Home and Science & Technology minister said.

“Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects,” Vij further said in his tweet. Bharat Biotech got the country’s drug regulator’s approval to start clinical trials of its anti-Corona vaccine Covaxin recently.

Also read: Portable Covid hospital developed: IIT Madras

There are over seven anti-corona vaccines at various stages of development in the country with two of them having received the drug regulator’s go-ahead to start the human clinical trials of their vaccines.

Earlier this month, Zydus had said it has received approval from authorities to start human trials for its anti-Covid-19 vaccine.

• CDSCO Nod granted to Conduct Clinical Trial of Ruxolitinib cream
• No provision for separate license for Pharma marketers
• Important short notes for Industry
• Deadly reactor explosion at Pharma Plant in Andhra Pradesh
• Drug recall: Dr Reddy’s recalls Cinacalcet Tablets due to impurity Concerns
• Indian Pharma Industry to face New GMP Regulations Compliance

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.